FRFrank Riemer

Frank Riemer

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Frank Riemer has a total of 266 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Metabolite‐Specific Reproducibility of Cerebral 31 P‐MRS at 3 T: Implications for Clinical Research

    by Magnus Svensen, Christian Dölle, Brage Brakedal, Haakon Berven, Njål Brekke, Alexander R. Craven, Erika Veslemøy Sheard, Arve Hjellbrekke, Vivian Skjeie, John Georg Seland, et al.

    Phosphorus magnetic resonance spectroscopy ( 31 P‐MRS) enables noninvasive measurement of brain metabolism, yet its reproducibility in clinical settings remains unclear. We systematically assessed intrasession and intersession variability as well as interindividual differences of key phosphorus metabolites at 3 T in healthy individuals and persons with Parkinson's disease under various experimental conditions. Intersession variability, as measured by coefficients of variation (CoVs) increased notably for longer scan intervals (~1 year), and metabolite ratios from well‐resolved spectral signals (i.e., adenosine triphosphate [ATP], phosphocreatine [PCr], and intracellular inorganic phosphate [P i ]) exhibited consistently higher stability compared with ratios calculated from metabolite signals overlapping on the spectrum (e.g., total nicotinamide adenine dinucleotide [tNAD], as well as phosphate monoesters [PMEs] and phosphate diesters [PDEs]). Test–retest variability ranged from ~5 to 25 CoV%, where PCr, ATP‐α, and ATP‐γ were the most stable while glycerophosphocholine (GPC), glycerophosphoethanolamine (GPE), phosphoethanolamine (PE), and tNAD varied considerably. Interindividual variability was found to be higher than intraindividual variability for all metabolite ratios, ranging from ~9 to 33 CoV%. By systematically quantifying intraindividual and interindividual variability, as well as providing explicit sample size recommendations, this study facilitates more reliable longitudinal and cross‐sectional clinical trials and translational studies of brain metabolism featuring 31 P‐MRS.


  • Open Access

    Metabolite-specific Reproducibility of Cerebral 31 P-MRS at 3T: Recommendations for Clinical Research

    by Magnus Svensen, Christian Dölle, Brage Brakedal, Haakon Berven, Njål Brekke, Alexander Richard Craig-Craven, Erika Veslemøy Sheard, Arve Hjellbrekke, Vivian Skjeie, John Georg Seland, et al.

    Phosphorus magnetic resonance spectroscopy ( 31 P-MRS) enables non-invasive measurement of brain metabolism, yet its reproducibility in clinical settings remains unclear. We systematically assessed intra- and intersession variability as well as inter-individual differences of key phosphorus metabolites at 3 Tesla in healthy individuals and persons with Parkinson’s disease under various experimental condition. Intersession variability, as measured by coefficients of variation (CoV) increased notably for longer scan intervals (∼1 year), and metabolite ratios from well-resolved spectral signals (i.e., adenosine triphosphate (ATP), phosphocreatine (PCr), intracellular inorganic phosphate P i ) exhibited consistently higher stability compared to ratios calculated from metabolite signals overlapping on the spectrum (e.g., total nicotinamide adenine dinucleotide (tNAD), as well as phosphate monoesters (PMEs) and phosphate diesters (PDEs). Test-retest variability ranged from ∼5-25 CoV%, where PCr, ATP-α and ATP-γ were the most stable while glycerophosphocholine (GPC), glycerophosphoethanolamine (GPE), phosphoethanolamine (PE) and tNAD varied considerably. Inter-individual variability was found to be higher than intra-individual variability for all metabolite ratios, ranging from ∼9-33 CoV%. By systematically quantifying intra-individual and inter-individual variability, as well as providing explicit sample-size recommendations, this study facilitates more reliable longitudinal and cross-sectional clinical trials and translational studies of brain metabolism featuring 31 P-MRS.

  • Open Access

    Acute and transient change in brain water content induced by a single electroconvulsive therapy session

    by Akihiro Takamiya, Frank Riemer, Vera Jane Erchinger, Max Korbmacher, Hauke Bartsch, Olga Therese Ousdal, Ivan Maximov, Anders Dale, Louise Emsell, Ketil Joachim Oedegaard, et al.


  • Open Access

    Deep-learning segmentation of the substantia nigra from multiparametric MRI: Application to Parkinson’s disease

    by Peder A.G. Lillebostad, Tormund H. Njølstad, Signe Hogstad, Frank Riemer, Simon U. Kverneng, Kjersti E. Stige, Martin Biermann, Mandar Jog, Sagar Buch, E. Mark Haacke, et al.

    Loss of dopaminergic neurons in the substantia nigra (SN) pars compacta (SNc) is a pathological hallmark of Parkinson’s disease (PD). This is accompanied by a reduction of the dopamine synthesis byproduct neuromelanin (NM), which can be detected in vivo with NM-sensitive MRI, showing potential as a biomarker of PD. This relies on delineating the NM-rich region, which is achieved by applying manual or automated methods. Currently, there is a lack of publicly available tools for this task, so we trained a deep neural network intended for publishing, while exploring the effects of incorporating multiparametric MRI for segmenting the NM hyperintensity of the SN. We obtained multiple MRI contrasts, including NM-sensitive magnetization transfer contrast from 109 individuals (87 PD, 22 healthy controls) comprising a Norwegian and a Canadian cohort. The method was further evaluated on 209 MRIs from the Parkinson’s Progressive Markers Initiative (PPMI). We observed that models trained naively on images from a single site tended to perform very poorly when exposed to similar data from different sites, emphasizing the importance of validating on out-of-distribution data. By applying aggressive data augmentation, we could largely attenuate the problem. We also observed a small additional regularizing effect from training the neural network on multiparametric MRIs. Volume and contrast-to-noise ratio (CNR) of the SN hyperintensity to the crus cerebri were used to distinguish patients from controls, with an area under the receiver operating characteristic (AUROC) of 0.863. CNR was found to be a better marker of disease status than volume, and we discuss a potential confusion in discerning the two measures. No contralateral association was observed between the severity of motor symptoms and volume or CNR.


  • Open Access

    Deep learning based image enhancement for dynamic non-Cartesian MRI: Application to “silent“ fMRI

    by Frank Riemer, Marius Eldevik Rusaas, Lydia Brunvoll Sandøy, Florian Wiesinger, Ana Beatriz Solana, Lars Ersland, Renate Grüner


  • Open Access

    The STRAT-PARK cohort: A personalized initiative to stratify Parkinson’s disease

    by Kjersti Eline Stige, Simon Ulvenes Kverneng, Soumya Sharma, Geir-Olve Skeie, Erika Sheard, Mona Søgnen, Solveig Af Geijerstam, Therese Vetås, Anne Grete Wahlvåg, Haakon Berven, et al.


  • Open Access

    Microstructural changes precede depression in patients with relapsing-remitting Multiple Sclerosis

    by Frank Riemer, Ellen Skorve, Ofer Pasternak, Fulvio Zaccagna, Astri J. Lundervold, Øivind Torkildsen, Kjell-Morten Myhr, Renate Grüner

    Background: Multiple Sclerosis lesions in the brain and spinal cord can lead to different symptoms, including cognitive and mood changes. In this study we explore the temporal relationship between early microstructural changes in subcortical volumes and cognitive and emotional function in a longitudinal cohort study of patients with relapsing-remitting Multiple Sclerosis.Methods: In vivo imaging in forty-six patients with relapsing-remitting Multiple Sclerosis was performed annually over 3 years magnetic resonance imaging. Microstructural changes were estimated in subcortical structures using the free water fraction, a diffusion-based MRI metric. In parallel, patients were assessed with the Hospital Anxiety and Depression Scale amongst other tests. Predictive structural equation modeling was set up to further explore the relationship between imaging and the assessment scores. In a general linear model analysis, the cohort was split into patients with higher and lower depression scores.Results: Nearly all subcortical diffusion microstructure estimates at the baseline visit correlate with the depression score at the 2 years follow-up. The predictive nature of baseline free water estimates and depression subscores after 2 years are confirmed in the predictive structural equation modeling analysis with the thalamus showing the greatest effect size. The general linear model analysis shows patterns of MRI free water differences in the thalamus and amygdala/hippocampus area between participants with high and low depression score.Conclusions: Our data suggests a relationship between higher levels of free-water in the subcortical structures in an early stage of Multiple Sclerosis and depression symptoms at a later stage of the disease.


  • Open Access

    Predicting Survival in Patients with Brain Tumors: Current State-of-the-Art of AI Methods Applied to MRI

    by Christian di Noia, James T. Grist, Frank Riemer, Maria Lyasheva, Miriana Fabozzi, Mauro Castelli, Raffaele Lodi, Caterina Tonon, Leonardo Rundo, Fulvio Zaccagna

    Given growing clinical needs, in recent years Artificial Intelligence (AI) techniques have increasingly been used to define the best approaches for survival assessment and prediction in patients with brain tumors. Advances in computational resources, and the collection of (mainly) public databases, have promoted this rapid development. This narrative review of the current state-of-the-art aimed to survey current applications of AI in predicting survival in patients with brain tumors, with a focus on Magnetic Resonance Imaging (MRI). An extensive search was performed on PubMed and Google Scholar using a Boolean research query based on MeSH terms and restricting the search to the period between 2012 and 2022. Fifty studies were selected, mainly based on Machine Learning (ML), Deep Learning (DL), radiomics-based methods, and methods that exploit traditional imaging techniques for survival assessment. In addition, we focused on two distinct tasks related to survival assessment: the first on the classification of subjects into survival classes (short and long-term or eventually short, mid and long-term) to stratify patients in distinct groups. The second focused on quantification, in days or months, of the individual survival interval. Our survey showed excellent state-of-the-art methods for the first, with accuracy up to ∼98%. The latter task appears to be the most challenging, but state-of-the-art techniques showed promising results, albeit with limitations, with C-Index up to ∼0.91. In conclusion, according to the specific task, the available computational methods perform differently, and the choice of the best one to use is non-univocal and dependent on many aspects. Unequivocally, the use of features derived from quantitative imaging has been shown to be advantageous for AI applications, including survival prediction. This evidence from the literature motivates further research in the field of AI-powered methods for survival prediction in patients with brain tumors, in particular, using the wealth of information provided by quantitative MRI techniques.


  • Open Access

    Hyperpolarized 13C-Pyruvate Metabolism as a Surrogate for Tumor Grade and Poor Outcome in Renal Cell Carcinoma—A Proof of Principle Study

    by Stephan Ursprung, Ramona Woitek, Mary A. McLean, Andrew N. Priest, Mireia Crispin-Ortuzar, Cara R. Brodie, Andrew B. Gill, Marcel Gehrung, Lucian Beer, Antony C. P. Riddick, et al.

    Differentiating aggressive clear cell renal cell carcinoma (ccRCC) from indolent lesions is challenging using conventional imaging. This work prospectively compared the metabolic imaging phenotype of renal tumors using carbon-13 MRI following injection of hyperpolarized [1-13C]pyruvate (HP-13C-MRI) and validated these findings with histopathology. Nine patients with treatment-naïve renal tumors (6 ccRCCs, 1 liposarcoma, 1 pheochromocytoma, 1 oncocytoma) underwent pre-operative HP-13C-MRI and conventional proton (1H) MRI. Multi-regional tissue samples were collected using patient-specific 3D-printed tumor molds for spatial registration between imaging and molecular analysis. The apparent exchange rate constant (kPL) between 13C-pyruvate and 13C-lactate was calculated. Immunohistochemistry for the pyruvate transporter (MCT1) from 44 multi-regional samples, as well as associations between MCT1 expression and outcome in the TCGA-KIRC dataset, were investigated. Increasing kPL in ccRCC was correlated with increasing overall tumor grade (ρ = 0.92, p = 0.009) and MCT1 expression (r = 0.89, p = 0.016), with similar results acquired from the multi-regional analysis. Conventional 1H-MRI parameters did not discriminate tumor grades. The correlation between MCT1 and ccRCC grade was confirmed within a TCGA dataset (p < 0.001), where MCT1 expression was a predictor of overall and disease-free survival. In conclusion, metabolic imaging using HP-13C-MRI differentiates tumor aggressiveness in ccRCC and correlates with the expression of MCT1, a predictor of survival. HP-13C-MRI may non-invasively characterize metabolic phenotypes within renal cancer.


  • Open Access

    Effects of Multi-Shell Free Water Correction on Glioma Characterization

    by Lea Starck, Fulvio Zaccagna, Ofer Pasternak, Ferdia A. Gallagher, Renate Grüner, Frank Riemer

    Diffusion MRI is a useful tool to investigate the microstructure of brain tumors. However, the presence of fast diffusing isotropic signals originating from non-restricted edematous fluids, within and surrounding tumors, may obscure estimation of the underlying tissue characteristics, complicating the radiological interpretation and quantitative evaluation of diffusion MRI. A multi-shell regularized free water (FW) elimination model was therefore applied to separate free water from tissue-related diffusion components from the diffusion MRI of 26 treatment-naïve glioma patients. We then investigated the diagnostic value of the derived measures of FW maps as well as FW-corrected tensor-derived maps of fractional anisotropy (FA). Presumed necrotic tumor regions display greater mean and variance of FW content than other parts of the tumor. On average, the area under the receiver operating characteristic (ROC) for the classification of necrotic and enhancing tumor volumes increased by 5% in corrected data compared to non-corrected data. FW elimination shifts the FA distribution in non-enhancing tumor parts toward higher values and significantly increases its entropy (p ≤ 0.003), whereas skewness is decreased (p ≤ 0.004). Kurtosis is significantly decreased (p < 0.001) in high-grade tumors. In conclusion, eliminating FW contributions improved quantitative estimations of FA, which helps to disentangle the cancer heterogeneity.